Regional Ventilation DIVA
Enrolling By Invitation
99 years or below
All
Phase
N/A
40 participants needed
1 Location
Brief description of study
To compare dependent lung ventilation (as assessed with EIT, vertical center of ventilation (CoV(v)) measure) between extremely preterm infants treated with NIV-NAVA and those treated with NS-NIPPV.
To compare global ventilation homogeneity (as assessed with EIT, global inhomogeneity index (GI) measure) between extremely preterm infants treated with NIV-NAVA to those treated with NS-NIPPV
To explore an association between regional lung ventilation (EIT, GI and silent space percentage (SS%) measure) at a single time point after extubation and subsequent extubation failure within 5 days of extubation among extremely preterm infants.
To assess the safety and feasibility of performing electrical impedance tomography in a population of preterm infants on non-invasive respiratory support. The primary outcome to be compared is the vertical center of ventilation (CoV(v)), a marker of dependent lung ventilation. Additional measures to be compared between respiratory support type and extubation success outcome include global inhomogeneity index (GI) and tidal volume impedance (TVi) as measures of ventilation homogeneity.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: 99 years or below
-
Gender: All
TBD
Updated on
17 Jun 2025.
Study ID: 23-1091
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245
Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.
Contact Office of Clinical ResearchPlease choose between Voice or SMS based delivery of verification code
or